Pierre Voet

1.2k total citations
19 papers, 1.0k citations indexed

About

Pierre Voet is a scholar working on Infectious Diseases, Epidemiology and Parasitology. According to data from OpenAlex, Pierre Voet has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Parasitology. Recurrent topics in Pierre Voet's work include Vector-borne infectious diseases (6 papers), Viral Infections and Vectors (6 papers) and Hepatitis B Virus Studies (5 papers). Pierre Voet is often cited by papers focused on Vector-borne infectious diseases (6 papers), Viral Infections and Vectors (6 papers) and Hepatitis B Virus Studies (5 papers). Pierre Voet collaborates with scholars based in Belgium, United States and Switzerland. Pierre Voet's co-authors include Philippe M. Hauser, Yves Lobet, Vincent Weynants, Howard C. Thomas, William F. Carman, Jennifer A. Waters, Lise Gern, Michael R. Hollingdale, Urszula Krzych and Joe Cohen and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

Pierre Voet

19 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Voet Belgium 15 438 334 284 259 220 19 1.0k
M Carl United States 22 196 0.4× 524 1.6× 475 1.7× 377 1.5× 198 0.9× 42 1.2k
Akira Oya Japan 17 490 1.1× 602 1.8× 121 0.4× 95 0.4× 291 1.3× 46 1.3k
Ming Qiao Australia 19 554 1.3× 423 1.3× 45 0.2× 427 1.6× 303 1.4× 36 1.1k
Randall W. Renshaw United States 20 397 0.9× 576 1.7× 50 0.2× 74 0.3× 174 0.8× 39 1.2k
T.F. McCaul United Kingdom 14 105 0.2× 265 0.8× 442 1.6× 35 0.1× 150 0.7× 33 802
Cyrille F. Djoko United States 17 264 0.6× 309 0.9× 46 0.2× 95 0.4× 199 0.9× 25 853
T P Monath United States 10 158 0.4× 443 1.3× 84 0.3× 98 0.4× 378 1.7× 10 815
Estela Escribano-Romero Spain 25 276 0.6× 1.1k 3.2× 83 0.3× 157 0.6× 1.0k 4.8× 52 1.7k
Gonzalo Moratorio Uruguay 21 248 0.6× 522 1.6× 32 0.1× 139 0.5× 392 1.8× 51 1.2k
James F. Cummings United States 16 395 0.9× 291 0.9× 273 1.0× 42 0.2× 675 3.1× 30 1.6k

Countries citing papers authored by Pierre Voet

Since Specialization
Citations

This map shows the geographic impact of Pierre Voet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Voet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Voet more than expected).

Fields of papers citing papers by Pierre Voet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Voet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Voet. The network helps show where Pierre Voet may publish in the future.

Co-authorship network of co-authors of Pierre Voet

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Voet. A scholar is included among the top collaborators of Pierre Voet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Voet. Pierre Voet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Voet, Pierre, et al.. (2025). Struggling with a cefazolin impregnation protocol of bone chips. Cell and Tissue Banking. 26(2). 11–11. 1 indexed citations
2.
He, Junkun, et al.. (2007). Characterization of monoclonal antibodies to hepatitis E virus (HEV) capsid protein and identification of binding activity. Journal of Biomedical Science. 14(5). 555–563. 12 indexed citations
3.
Pettersson, Annika, Jeroen Kortekaas, Vincent Weynants, et al.. (2006). Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB. Vaccine. 24(17). 3545–3557. 40 indexed citations
4.
Voet, Pierre, et al.. (2005). Industrial Implementation of in Vitro Production of Monoclonal Antibodies. ILAR Journal. 46(3). 307–313. 21 indexed citations
5.
Bos, Martine P., Boris Tefsen, Pierre Voet, et al.. (2005). Function of Neisserial Outer Membrane Phospholipase A in Autolysis and Assessment of Its Vaccine Potential. Infection and Immunity. 73(4). 2222–2231. 48 indexed citations
6.
Gorringe, Andrew, Karen M. Reddin, Pierre Voet, & Jan Poolman. (2003). Animal Models for Meningococcal Disease. Humana Press eBooks. 66. 241–254. 10 indexed citations
7.
Pal, Utpal, Ruth R. Montgomery, Denise Lusitani, et al.. (2001). Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody. The Journal of Immunology. 166(12). 7398–7403. 65 indexed citations
8.
Liang, Fang Ting, Elisabeth Aberer, Marina Cinco, et al.. (2000). Antigenic Conservation of an Immunodominant Invariable Region of the VlsE Lipoprotein among European Pathogenic Genospecies ofBorrelia burgdorferiSL. The Journal of Infectious Diseases. 182(5). 1455–1462. 71 indexed citations
10.
Gern, Lise, Chang Min Hu, Pierre Voet, Pierre Hauser, & Yves Lobet. (1997). Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii. Vaccine. 15(14). 1551–1557. 42 indexed citations
11.
Golde, William T., Joseph Piesman, M. C. Dolan, et al.. (1997). Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi. Infection and Immunity. 65(3). 882–889. 48 indexed citations
12.
Gordon, Daniel M., Thomas W. McGovern, Urszula Krzych, et al.. (1995). Safety, Immunogenicity, and Efficacy of a Recombinantly Produced Plasmodium falciparum Circumsporozoite Protein-Hepatitis B Surface Antigen Subunit Vaccine. The Journal of Infectious Diseases. 171(6). 1576–1585. 235 indexed citations
13.
Gern, Lise, Olivier Rais, C Capiau, et al.. (1994). Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites. Immunology Letters. 39(3). 249–258. 35 indexed citations
15.
Waters, Jennifer A., et al.. (1992). Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.. Journal of Clinical Investigation. 90(6). 2543–2547. 178 indexed citations
16.
Jacobs, P, et al.. (1991). Plasmodium falciparum: recombinant baculoviruses direct the expression of circumsporozoite proteins in Spodoptera frugiperda cell cultures. Molecular Biology Reports. 15(2). 73–79. 5 indexed citations
17.
Petit, Marie-Anne, et al.. (1991). HepG2 cell binding activities of different hepatitis b virus isolates: inhibitory effect of anti-HBs and anti-preS1(21–47). Virology. 180(2). 483–491. 55 indexed citations
18.
Jacobs, Eric J., Tineke Rutgers, Pierre Voet, et al.. (1989). Simultaneous synthesis and assembly of various hepatitis B surface proteins in Saccharomyces cerevisiae. Gene. 80(2). 279–291. 28 indexed citations
19.
Hauser, Philippe M., et al.. (1987). Immunological properties of recombinant HBsAg produced in yeast.. PubMed. 63 Suppl 2. 83–91. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026